Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 1,561,392 | 1,017,110 | 1,633,232 | 1,293,738 | 1,304,241 | 6,809,713 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 1,561,392 | 1,017,110 | 1,633,232 | 1,293,738 | 1,304,241 | 6,809,713 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 3,006,140 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 3,803,573 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 1,561,392 | 1,017,110 | 1,633,232 | 1,293,738 | 1,304,241 | 6,809,713 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 28,028 | 20,513 | 137 | 7,492 | 30,853 | 87,023 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | 6,896,736 | |||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2023 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2023 |
(iii) Distributable Amount for 2023 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2023 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2023 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2023: | ||||
| a From 2018....... | ||||
| b From 2019....... | ||||
| c From 2020....... | ||||
| d From 2021....... | ||||
| e From 2022....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2023 distributable amount | ||||
|
i
Carryover from 2018 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2023 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2023 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2023, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2023. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2024. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2019..... | ||||
| b Excess from 2020..... | ||||
| c Excess from 2021..... | ||||
| d Excess from 2022..... | ||||
| e Excess from 2023..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 2 | IN 2023, WE LAUNCHED DIGITAL HEALTH KC TO CREATE IDEAL CONDITIONS FOR A VIBRANT DIGITAL HEALTH ECOSYSTEM AND TO CATALYZE COLLABORATION IN DIGITAL HEALTH. THROUGH OUR WORK, DIGITAL HEALTH KC WILL ESTABLISH THE KC REGION AS A TOP 3 PLACE TO START, GROW, AND RETAIN A DIGITAL HEALTH BUSINESS, ENABLE 10 DIGITAL HEALTH UNICORNS, AND GROW THE REGIONAL DIGITAL HEALTH ECOSYSTEM TO OVER 125+ COMPANIES. |
| FORM 990, PART III, LINE 4A | 1. CHARTING A BOLD COURSE FORWARD: THE "PATH TO 2025" IN 2023, BIONEXUS KC PROPELLED FORWARD ON ITS "PATH TO 2025" PLAN, DEVISED IN COLLABORATION WITH DELOITTE IN 2015. FOCUSED ON ANIMAL HEALTH, HEALTHCARE IT, CANCER RESEARCH, AND NEUROSCIENCE, THE REGION'S STRENGTHS ALIGNED SEAMLESSLY WITH EMERGING MARKET TRENDS. THE REPORT ALSO EMPHASIZED THE IMPORTANCE OF FORTIFYING WORKFORCE DEVELOPMENT, CAPITAL FORMATION, COLLABORATION, AND REGIONAL MARKETING. SIGNIFICANT STRIDES WERE ACHIEVED IN HEALTHCARE IT, NOTABLY MARKED BY THE LAUNCH OF DIGITAL HEALTH KC IN MAY. THIS SECTOR, ONCE SYNONYMOUS WITH CERNER, HAS EVOLVED INTO A DIVERSE ECOSYSTEM COMPRISING OVER 100 COMPANIES AND A WORKFORCE OF MORE THAN 25,000. THE KC REGION HAS SOLIDIFIED ITS POSITION AS A TOP TIER DESTINATION FOR PIONEERING DIGITAL HEALTH VENTURES. BEYOND EXPECTATIONS, KANSAS CITY ALSO EARNED RECOGNITION AS A TECH HUB - A SIGNIFICANT MILESTONE NOT EXPLICITLY OUTLINED IN THE INITIAL PLAN. THE IMPORTANCE OF BIOLOGICS ACROSS ALL FOCUS AREAS BECAME INCREASINGLY APPARENT, CALLING FOR STRATEGIC INVESTMENTS IN WORKFORCE DEVELOPMENT, CAPITAL, COLLABORATION, AND MARKETING. WITH MANUFACTURING FACILITIES FOR FOUR TOP VACCINE COMPANIES, INCLUDING A PIVOTAL ROLE BY PFIZER IN COVID-19 VACCINE PRODUCTION, KANSAS CITY'S BIOTECH SECTOR IS AT THE FOREFRONT OF INNOVATION. WITH EACH MILESTONE ACHIEVED, BIONEXUS KC SOLIDIFIES ITS ROLE AS AN INNOVATION CATALYST, DRIVING THE REGION FORWARD ON ITS PATH TOWARD A TRANSFORMATIVE AND PROSPEROUS FUTURE. AS THE JOURNEY PROGRESSES, BIONEXUS KC REMAINS COMMITTED TO BOLSTERING THE KC REGION AS A GLOBAL LEADER AT THE NEXUS OF HUMAN AND ANIMAL HEALTH BENEFITING ALL OUR CITIZENS AND THE ECONOMY. 2. REVOLUTIONIZING HEALTH TECH: BIONEXUS KC LAUNCHES DIGITAL HEALTH KC IN MARCH OF 2023, BIONEXUS KC LAUNCHED DIGITAL HEALTH KC, PROPELLING THE REGION INTO THE FOREFRONT OF DIGITAL HEALTH INNOVATION. AT THE CENTER OF HEALTH + DATA, THE ORGANIZATION WILL ADVANCE THE KC REGION'S DIGITAL HEALTH CLUSTER. DIGITAL HEALTH KC IS A CATALYST FOR CHANGE WITH A MISSION TO CULTIVATE A VIBRANT ECOSYSTEM, FOSTER COLLABORATION, AND SEAMLESSLY CONNECT CRITICAL ELEMENTS SUCH AS IDEAS, TALENT, COMPANIES, CAPITAL, AND CUSTOMERS, IT REPRESENTS A PIVOTAL LEAP FORWARD FOR HEALTHCARE INNOVATION. SETTING ITS SIGHTS HIGH, DIGITAL HEALTH KC ASPIRES TO POSITION THE KC REGION AMONG THE TOP THREE DESTINATIONS FOR STARTING, GROWING, AND RETAINING DIGITAL HEALTH BUSINESSES. THE INITIATIVE AIMS TO FOSTER THE GROWTH OF THE DIGITAL HEALTH ECOSYSTEM, ENVISIONING 125+ COMPANIES CONTRIBUTING TO THE REGIONAL LANDSCAPE. ADDITIONALLY, DIGITAL HEALTH KC IS DEDICATED TO NURTURING TEN DIGITAL HEALTH UNICORNS, MARKING A SIGNIFICANT MILESTONE IN PRIVATELY OWNED STARTUPS VALUED AT OVER $1 BILLION. BEYOND ECONOMIC DEVELOPMENT, THIS ROBUST INFRASTRUCTURE HOLDS THE POTENTIAL FOR AMPLE IMPROVEMENT IN DIGITAL HEALTH QUALITY AND COST REDUCTIONS. BY ADDRESSING HEALTH INEQUITIES, IT AIMS TO MAKE A LASTING IMPACT IN BOTH URBAN AND RURAL AREAS THROUGHOUT THE KC REGION. DIGITAL HEALTH KC WILL CREATE A CONNECTED AND COLLABORATIVE ECOSYSTEM THAT SPANS DIGITAL HEALTH COMPANIES, HEALTH SYSTEMS, RESEARCH INSTITUTIONS, UNIVERSITY PAYERS, INVESTORS, PROFESSIONAL SERVICES, AND INDUSTRIES ADJACENT TO DIGITAL HEALTH. THIS COMPREHENSIVE NETWORK INCLUDES PHARMA, BIOTECH, DIAGNOSTICS, DEVICES, AND MEDICAL SUPPLY SECTORS. THE LAUNCH CELEBRATION OF DIGITAL HEALTH KC TOOK PLACE IN MAY OF 2023, AT BOULEVARD BREWING COMPANY. BIONEXUS KC, ALONGSIDE EARLY SUPPORTERS AND PARTNERS SUCH AS KC DIGITAL DRIVE, KANSAS CITY AREA DEVELOPMENT COUNCIL, AND PIPELINE ENTREPRENEURS, CAME TOGETHER TO CELEBRATE THIS SIGNIFICANT MILESTONE THAT PROMISES TO RESHAPE THE FUTURE OF HEALTHCARE INNOVATION IN THE KC REGION. 3. CELEBRATING TECH HUBS: KC BIOHUB DESIGNATION TRANSFORMING VACCINES THE US ECONOMIC DEVELOPMENT ADMINISTRATION DESIGNATED THE KC REGION AS A TECH HUB IN A GROUNDBREAKING INVESTMENT TO BOLSTER THE NATION'S ECONOMY AND SECURITY. LED BY BIONEXUS KC AND BACKED BY OVER 60 PARTNER ORGANIZATIONS, THE REGIONAL PROPOSAL - KANSAS CITY INCLUSIVE BIOLOGICS AND BIOMANUFACTURING TECH HUB (KC BIOHUB), IS SET TO REVOLUTIONIZE VACCINE PRODUCTION AND OTHER PREVENTATIVE TECHNOLOGIES. LEVERAGING REGIONAL ASSETS AND A ROBUST ECOSYSTEM, THE INITIATIVE AIMS TO POSITION KC AS A GLOBAL BIOMANUFACTURING AND LIFE SCIENCES LEADER. KC BIOHUB IS NOW ELIGIBLE FOR PHASE 2 FUNDING OF UP TO $75 MILLION. THE TECH HUBS PROGRAM PASSED WITH THE CHIPS AND SCIENCE ACT OF 2022, ALLOCATES OVER $10 BILLION OVER FIVE YEARS TO DRIVE ECONOMIC DEVELOPMENT IN COMMUNITIES LIKE THE KC REGION. THE FEDERAL INITIATIVE AIMS TO EQUIP THE US WITH A COMPETITIVE TECHNOLOGICAL EDGE, FOSTERING ECONOMIC GROWTH AND A TECH WORKFORCE. KC WAS CHOSEN AS ONE OF THE 31 TECH HUBS OUT OF OVER 370 APPLICATIONS. THE RECOGNITION POSITIONS KC AS A NATIONAL STANDOUT IN LIFE SCIENCES AND BIOMANUFACTURING. 4. COLLABORATING FOR RARE DISEASE: BIONEXUS KC AND RAREKC HOST IMPACTFUL SERIES BIONEXUS KC AND RAREKC JOINED FORCES TO CO-HOST THE COLLABORATE2CURE: RARE DISEASE SERIES. THIS STRATEGIC PARTNERSHIP ENHANCED THE IMPACT OF THE SERIES, DESIGNED EXPLICITLY TO FOSTER COLLABORATION ACROSS THE KC REGION AND TACKLE SCIENTIFIC CHALLENGES SURROUNDING RARE DISEASE, FOCUSING ON INNOVATIVE TREATMENTS AND ADVOCACY STRATEGIES RELATED TO RARE DISEASE PATIENTS, FAMILIES, AND CAREGIVERS. LAUNCHING IN JANUARY 2023, THE SERIES CONDUCTED SIX THOUGHT-PROVOKING SESSIONS, INCLUDING A SPECIAL EVENT COMMEMORATING RARE DISEASE DAY. TOPICS RANGED FROM THE STATE OF RARE DISEASE TO BIG DATA APPLICATIONS, ATTRACTING OVER 900 SCIENTISTS, COMMUNITY MEMBERS, STUDENTS, PATIENTS/FAMILIES, AND ENTREPRENEURS. THESE SESSIONS STIMULATED COLLABORATION AND INNOVATION, EXPLORING DIVERSE RESEARCH AND CLINICAL ISSUES TO SPARK CONVERSATIONS AND STRATEGIES WITHIN THE RARE DISEASE COMMUNITY. THE COLLABORATE2CURE RARE DISEASE SERIES SHOWCASED A MYRIAD OF NATIONAL AND REGIONAL LEADERS TO ADDRESS UNMET NEEDS AND CHALLENGES. THE SERIES, DRIVEN BY A COMMITMENT TO RAISING AWARENESS AND GENERATING MEANINGFUL CHANGE, ALSO SOUGHT TO EXPLORE INNOVATIVE FUNDING MODELS, ENCOURAGE COLLABORATIVE SOLUTIONS, AND LEVERAGE THE UNIQUE STRENGTHS OF THE KC REGION TO ESTABLISH ITSELF AS A GLOBAL LEADER IN RARE DISEASE RESEARCH, DIAGNOSIS, AND CARE. BIONEXUS KC WAS HONORED WITH A 2023 PHILLY AWARD FROM NONPROFIT CONNECT FOR MARKETING EXCELLENCE IN THE COLLABORATIVE CATEGORY FOR THE WORK WITH RAREKC ON THE COLLABORATE2CURE: RARE DISEASE SERIES. 5. SHAPING RESPONSIBLE AI PRACTICES: ETHICAL AI TRANSFORMS HEALTHCARE IN KC THE ETHICAL AI INITIATIVE, HEADQUARTERED AT THE CENTER FOR PRACTICAL BIOETHICS AND A BIONEXUS KC PARTNER, PROMOTES RESPONSIBLE AI FOR BETTER HEALTH OUTCOMES. IN 2023, THE INITIATIVE FOCUSED ON COMMUNITY ENGAGEMENT, DELIVERING PRESENTATIONS AT 13 EVENTS IN KANSAS CITY AND VIRTUALLY, ENGAGING DIVERSE AUDIENCES RANGING FROM STUDENTS TO HEALTHCARE PROFESSIONALS. COLLABORATING WITH HEALTHCARE ORGANIZATIONS, THE INITIATIVE PARTNERED WITH CHILDREN'S MERCY FOR ITS ETHICAL AI WORKSHOP, PILOTING A CURRICULUM BY THEIR ADVISORY COUNCIL. THEY ALSO CONDUCTED A GLOBAL ANALYSIS, FOSTERED ETHICAL AI DISCUSSIONS WITH LOCAL STARTUPS, AND SET AMBITIOUS GOALS FOR THE FUTURE. LINDSEY JARRETT, PHD, LED THE INITIATIVE, ALSO MENTORING IN NIH'S AIM-AHEAD PROGRAM, AIMED AT ADVANCING HEALTH EQUITY AND DIVERSITY IN AI. THE INITIATIVE'S FUNDING PRIMARILY COMES FROM COMMUNITY GRANTS AND SUPPORT FROM KANSAS CITY FOUNDATIONS. BIONEXUS KC CONTINUES TO GUIDE THE INITIATIVE'S DEVELOPMENT, ENSURING A STEADFAST COMMITMENT TO GROWTH AND SUSTAINABILITY. |
| FORM 990, PART III, LINE 4A | 6. DISMANTLING HEALTH DISPARITIES: REGIONAL GROUPS DRIVE SYSTEMIC CHANGE THROUGH THE HEALTH EQUITY LEARNING AND ACTION NETWORK (HE-LAN) THE KANSAS CITY HEALTH EQUITY LEARNING AND ACTION NETWORK (LAN), LED BY THE HEALTH FORWARD FOUNDATION AND PARTNERED WITH THE INSTITUTE FOR HEALTHCARE IMPROVEMENT AND KC HEALTH COLLABORATIVE, IS DEDICATED TO DISMANTLING RACIALLY BIASED HEALTH SYSTEMS. WITH OVER 50 PARTICIPATING ORGANIZATIONS, INCLUDING CLINICIANS, PUBLIC HEALTH ENTITIES, AND COMMUNITY-BASED GROUPS, LAN AIMS TO ELIMINATE HEALTH DISPARITIES AND PROMOTE EQUITABLE HEALTH OUTCOMES FOR PEOPLE OF COLOR. BIONEXUS KC ACTIVELY ENGAGES IN THESE EFFORTS, CONTRIBUTING RESOURCES AND EXPERTISE TO DRIVE SYSTEMIC CHANGE. LAN MEMBERS HAVE COMMITTED TO PRIORITIZING DIVERSITY AND INCLUSIVITY, WITH CEOS AGREEING TO DIVERSIFY THEIR BOARDS OF DIRECTORS WITH PEOPLE OF COLOR. ADDITIONALLY, LAN MEMBERS ARE DEDICATED TO IMPLEMENTING ANTI-RACIST PRACTICES WITHIN THEIR INSTITUTIONS. FIFTEEN ACTION TEAMS ARE FOCUSED ON UNDERSTANDING AND ADDRESSING RACIAL HEALTH INEQUITIES, EMPLOYING EQUITY-CENTERED METHODOLOGIES TO IDENTIFY AND RECTIFY PRACTICES PERPETUATING HEALTH INJUSTICES. THROUGH COLLABORATION AND CONCERTED EFFORTS, LAN SEEKS TO REALIZE TANGIBLE IMPROVEMENTS IN HEALTHCARE DELIVERY, ENSURING EQUITABLE ACCESS AND OUTCOMES FOR ALL INDIVIDUALS, REGARDLESS OF RACE OR ETHNICITY. 7. DEI THE PATH TO 2025 CONTINUED TO EVOLVE AND NEW PRIORITIES WERE IDENTIFIED BY REGIONAL PARTNERS. ONE PRIMARY FOCUS OF MANY REGIONAL ORGANIZATIONS IS HEALTH EQUITY AND DIVERSITY, EQUITY, AND INCLUSION (DEI) INITIATIVES. THE ROLE OF BIONEXUS KC IS TO IMPROVE OUTCOMES FOR ALL AND REDUCE THE INEQUITIES THAT EXIST BETWEEN WHITE AND BLACK KANSAS CITIANS. SCIENTIFIC PRIORITY AREAS OF OPPORTUNITY LIKE RARE DISEASE AND BIOLOGICS CUT ACROSS ALL FOUR SCIENTIFIC AREAS ORIGINALLY INCLUDED AND ARE NOW KEY AREAS OF FOCUS. IN 2022 BIONEXUS KC EXPANDED THE DEI COMMITTEE, COMPOSED OF DEI LEADERS FROM BIONEXUS KC STAKEHOLDER INSTITUTIONS. THE BIONEXUS KC DEI COMMITTEE SERVES AS AN ADVISORY BODY TO REGIONAL HEALTHCARE AND LIFE SCIENCE LEADERSHIP, OFFERING GUIDANCE IN THESE AREAS AS REQUESTED. THE BIONEXUS KC DEI COMMITTEE MET QUARTERLY IN 2023 TO HELP INTEGRATE BEST PRACTICES FOR DIVERSITY, EQUITY, AND INCLUSION INTO REGIONAL STAKEHOLDER POLICIES AND PROGRAMS AND TO SHARE CURRENT PROGRAMS AND BEST PRACTICES. ADDITIONALLY, THE BIONEXUS KC DEI COMMITTEE PROVIDED EDUCATION AND ENRICHMENT OPPORTUNITIES FOR ITS MEMBERS AND SERVES AS A FORUM FOR DISCUSSION OF SUBSTANTIVE BEST PRACTICES. 8. BIONEXUS KC RESEARCH GRANTS PROGRAM: ADVANCING PEDIATRIC TREATMENTS BIONEXUS KC, IN COLLABORATION WITH THE PAUL PATTON TRUST, AWARDED $150,000 IN OCTOBER 2023 TO REGIONAL SCIENTISTS IN OCTOBER 2023, PROVIDING THREE $50,000 GRANTS FOR PIONEERING LOCAL RESEARCHERS DEDICATED TO INNOVATING IN CHILDHOOD DISEASE PREVENTION, DIAGNOSIS, AND TREATMENT. WITH A LEGACY OF 51 GRANTS AND OVER $2.6M SINCE 2007, THE IMPACT OF BIONEXUS KC EXTENDS BEYOND THE INITIAL INVESTMENT, BOASTING A REMARKABLE RETURN OF MORE THAN $10 TO THE REGION FOR EVERY DOLLAR AWARDED. THIS ISN'T JUST FUNDING; IT'S A COMMITMENT TO TRANSFORMING THE LANDSCAPE OF PEDIATRIC DISEASE RESEARCH. A BRIEF DESCRIPTION OF EACH GRANT RECIPIENT'S RESEARCH IS BELOW. SEARCHING FOR INSIGHTS INTO THE GENETIC BASIS OF CRANIOFACIAL MICROSOMIA: CHILDREN WITH CRANIOFACIAL MICROSOMIA (CFM) EXPERIENCE ABNORMAL FORMATION OF FACIAL FEATURES, IMPACTING AREAS SUCH AS THE EARS, JAW, EYES, CHEEKS, AND NECK BONES. THIS CONGENITAL DISABILITY CAN LEAD TO FEEDING, BREATHING, CHEWING, HEARING, AND SPEECH CHALLENGES, WITH TREATMENTS VARYING BASED ON AGE AND SYMPTOM SEVERITY. TIMOTHY COX, PHD, ENDOWED PROFESSOR IN DENTAL & MUSCULOSKELETAL TISSUE RESEARCH AT THE UNIVERSITY OF MISSOURI KANSAS CITY, AND COLLABORATOR PAUL TRAINOR, PHD, INVESTIGATOR AT THE STOWERS INSTITUTE FOR MEDICAL RESEARCH, AIM TO UNCOVER NEW GENETIC VARIANTS AND ENHANCE UNDERSTANDING OF CFM, ULTIMATELY INFLUENCING PATIENT CARE POSITIVELY. DEVELOPING DIAGNOSTIC & PROFILING TOOLS FOR OSTEOSARCOMA PATIENTS: OSTEOSARCOMA (OS) IS THE MOST PREVALENT BONE CANCER, OFTEN IMPACTING THE LONG BONES IN ARMS AND LEGS AND PRESENTING SYMPTOMS LIKE LIMITED MOVEMENT, BONE PAIN, LUMP FORMATION, AND AN INCREASED RISK OF FRACTURES. EARLY DETECTION CAN ENHANCE THE FIVE-YEAR SURVIVAL RATE BY UP TO 60%, MAKING ACCURATE IDENTIFICATION CRUCIAL. KANSAS STATE UNIVERSITY PROFESSOR SHIH-KANG "SCOTT" FAN, PHD, AND HIS TEAM ARE DEDICATED TO DEVELOPING MINIMALLY INVASIVE DIAGNOSTIC TOOLS FOR EARLY OS DETECTION, ALONG WITH ADVANCED TECHNIQUES FOR IMPROVED LAB AND CLINICAL PROFILING. DEVELOPING TARGETED THERAPIES FOR FUSION-DRIVEN CANCERS: FUSION-DRIVEN CANCERS ARISE FROM CELL DIVISION ERRORS, CAUSING UNINTENDED DNA FUSIONS THAT RESULT IN GENE DYSFUNCTION AND UNCONTROLLED CELL GROWTH, LEADING TO TREATMENT RESISTANCE IN CASES LIKE LYMPHOMA AND LEUKEMIA. RAMESH BALUSU, PHD, ASSISTANT PROFESSOR AT THE UNIVERSITY OF KANSAS MEDICAL CENTER, AND HIS TEAM WILL TARGET SPECIFIC PROTEINS TO ANALYZE AND DEVELOP INNOVATIVE THERAPIES FOR FUSION-DRIVEN LYMPHOMAS AND LEUKEMIAS. 9. ADDRESSING BIOTECH WORKFORCE: TRAINING PROGRAMS ENSURING EQUITABLE ACCESS IN LATE 2023, KANSAS CITY EMBARKED ON A TRANSFORMATIVE JOURNEY BY LAUNCHING AN INNOVATIVE INITIATIVE SPEARHEADED BY BIONEXUS KC AND STATEWIDE PARTNERS. THIS INITIATIVE ADDRESSES THE URGENT NEED FOR INDUSTRY-DRIVEN BIOMANUFACTURING AND BIOTECHNOLOGY WORKFORCE TRAINING PROGRAMS WHILE ENSURING EQUITABLE ACCESS ACROSS URBAN AND RURAL COMMUNITIES. AS BIOTECH FOR MISSOURI GRANT RECIPIENTS, BIONEXUS KC AND PARTNERS DILIGENTLY CRAFT COMPREHENSIVE TRAINING MODULES TO CATER TO VARIOUS SKILL LEVELS. THE ALLOCATED ARPA (DED WORKFORCE DEVELOPMENT TRAINING GRANT THROUGH BIOSTL) FUNDS FOR BIONEXUS KC WILL SUPPORT ACCESS TO LOCAL OPPORTUNITIES AND TRAINING FOR 150 OUT OF 900 INDIVIDUALS INTO QUALITY, MIDDLE-SKILL JOBS WITH CAREER MOBILITY INTO HIGH-SKILL JOBS WITHIN 42 MONTHS. EMPHASIZING INCLUSIVITY, THE PROGRAM AIMS FOR 75% OF PARTICIPANTS FROM HISTORICALLY MARGINALIZED BACKGROUNDS. METROPOLITAN COMMUNITY COLLEGE (MCC) PLAYS A CRUCIAL ROLE IN CURRICULUM DEVELOPMENT AND INFRASTRUCTURE ENHANCEMENT AND WILL SUSTAIN THE PROGRAM. FORMALIZING A MEMORANDUM OF UNDERSTANDING (MOU) BETWEEN BIONEXUS KC AND MCC SIGNIFIES A SHARED COMMITMENT TO ADVANCING WORKFORCE DEVELOPMENT AGENDAS. DESPITE PROCEDURAL HURDLES, EFFORTS ARE UNDERWAY TO EXPEDITE ESSENTIAL ACTIVITIES. WHILE RECRUITMENT AND FACILITY RENOVATIONS OCCUR, BIONEXUS KC AND MCC IDENTIFIED A UNIQUE WAY TO ADMINISTER NON-CREDIT TECHNICAL SKILLS TRAINING BEFORE CONSTRUCTION IS COMPLETE. IN 2024, MCC WILL BEGIN AN INTRODUCTORY BASIC LABORATORY METHODS FOR BIOTECHNOLOGY COURSE. THIS COURSE WILL INTRODUCE STUDENTS TO SKILLS REQUIRED TO WORK IN AN ENTRY-LEVEL POSITION IN A CLINICAL LABORATORY. ALTHOUGH RENOVATION EFFORTS AT MCC'S PENN VALLEY CAMPUS ARE EXPECTED TO CONCLUDE IN 2025, INTRODUCTORY CLASSES STARTING IN 2024 WILL SERVE AS FEEDER COURSES TO THE LONG-TERM PROGRAM WHICH WILL INCLUDE INDUSTRY-RECOGNIZED CREDENTIALS. THE COLLABORATIVE EFFORTS OF BIONEXUS KC, MCC, AND ALLIED PARTNERS HERALD A NEW ERA OF INNOVATION AND INCLUSIVITY IN BIOTECHNOLOGY WORKFORCE DEVELOPMENT IN KANSAS CITY. THROUGH STRATEGIC ALLIANCES AND TARGETED INVESTMENTS, THESE INITIATIVES EMPOWER INDIVIDUALS WITH THE SKILLS AND OPPORTUNITIES NEEDED TO THRIVE IN A DYNAMIC INDUSTRY LANDSCAPE. THESE COLLECTIVE ENDEAVORS SERVE AS A TESTAMENT TO THE TRANSFORMATIVE POWER OF COLLABORATION IN DRIVING SOCIOECONOMIC ADVANCEMENT AND FOSTERING INCLUSIVE GROWTH. 10. DISRUPTING REGIONAL INNOVATION: ANNUAL EVENT INSPIRES ACTION FOR CHANGE NEARLY 500 LIFE SCIENCES LEADERS, EXECUTIVES, AND STUDENTS ATTENDED THE BIONEXUS KC ANNUAL EVENT, LEVERAGING POSITIVE DISRUPTION TO ADVANCE LIFE SCIENCES AND TRANSFORM THE REGIONAL LANDSCAPE. THE EVENING FEATURED KEYNOTE MARCUS WHITNEY, FOUNDING PARTNER OF JUMPSTART HEALTH INVESTORS, WHO LEADS AMERICA'S MOST ACTIVE EARLY-STAGE HEALTHCARE VENTURE CAPITAL FIRM. AS THE #1 BEST-SELLING AUTHOR OF CREATE & ORCHESTRATE," HE EMPOWERS ENTREPRENEURS TO CLAIM THEIR CREATIVE POWER IN THE BUSINESS WORLD. HIGHLIGHTING THE TRANSFORMATIVE POWER OF COMMUNITY-BUILDING, WHITNEY EMPHASIZED THE IMPACT OF COLLABORATION, EXTENDING BEYOND HEALTHCARE TO INITIATIVES SUCH AS BRINGING PROFESSIONAL SOCCER TO HIS HOMETOWN. WHITNEY ALSO TOUCHED ON RACIAL ISSUES IN 2020 AND HOW HE USED HIS POSITION TO INITIATE IMPACTFUL PROJECTS SUCH AS JUMPSTART NOVA, THE FIRST BLACK HEALTHCARE VENTURE FUND IN AMERICA. HE CONCLUDED HIS REMARKS WITH A POWERFUL MESSAGE, URGING THE AUDIENCE TO RECOGNIZE THEIR STRENGTHS, BELIEVE IN THEIR VISION, AND WORK COLLABORATIVELY FOR POSITIVE CHANGE TO DISRUPT THE NORM IN HEALTHCARE AND BEYOND. |
| FORM 990, PART III, LINE 4A | 11. "SCIENCE2ART" - CONNECTING ART AND SCIENCE TO SUPPORTS STEAM PROGRAMS ENERGIZING THE INTERSECTION OF SCIENCE AND ART, THE BIONEXUS KC SCIENCE2ART PROGRAM FUELS IMAGINATION AND INQUIRY. BY SEAMLESSLY BLENDING VISUAL EXPRESSION WITH RESEARCH, THE INITIATIVE IMMERSES THE COMMUNITY IN A DYNAMIC EXPLORATION, IGNITING PROFOUND QUESTIONS AND UNCOVERING NEW INSIGHTS. THE RESULTING ARTWORK DEEPENS UNDERSTANDING OF STEAM CONCEPTS AND INVIGORATES INNOVATION. REGIONAL RESEARCHERS SUBMIT ARTWORK TO BE CAREFULLY CURATED AND PROFESSIONALLY PRINTED AND FRAMED. THE ARTWORK IS THEN AUCTIONED TO THE COMMUNITY WITH ALL PROCEEDS SUPPORTING REGIONAL STEAM INITIATIVES. SINCE ITS INCEPTION IN 2014, THE PROGRAM HAS DONATED OVER $160,000 TO SUPPORT LOCAL ORGANIZATIONS CHAMPIONING STEAM EDUCATION. THIS INVESTMENT PROPELS THE NEXT GENERATION OF INNOVATORS, EMPOWERING THEM TO TACKLE CHALLENGES IN NEW AND CREATIVE WAYS. 12. EVENTS -NEXUS INFORMATICS CONFERENCE: CULTIVATING GROWTH IN INFORMATICS - CONFERENCE SPOTLIGHTS LATEST ADVANCEMENTS THE 2023 NEXUS INFORMATICS CONFERENCE, HELD AT THE CHILDREN'S MERCY RESEARCH INSTITUTE IN KANSAS CITY AND HOSTED BY BIONEXUS KC, CONVENED 180 ATTENDEES FROM VARIOUS SECTORS, CREATING A VIBRANT PLATFORM FOR KNOWLEDGE EXCHANGE AND COLLABORATION. WITH A LINEUP OF 45 SPEAKERS ACROSS DIVERSE FIELDS, THE CONFERENCE FACILITATED INSIGHTFUL DISCUSSIONS IN AN INCLUSIVE ATMOSPHERE. NEIL SARKAR, PHD, MLIS, FACMI, FROM THE RHODE ISLAND QUALITY INSTITUTE, KICKED OFF DAY ONE WITH AN INSIGHTFUL DISCUSSION ON ELECTRONIC HEALTH RECORDS (EHR) AND THEIR INFLUENCE ON CONTEMPORARY HEALTHCARE. SARKAR EMPHASIZED HOW EHR SYSTEMS CAN REVOLUTIONIZE MEDICAL ACCESS BY MAKING COMPREHENSIVE MEDICAL HISTORIES MORE WIDELY AVAILABLE, SETTING THE STAGE FOR INVENTIVE HEALTHCARE SOLUTIONS. DURING THE SECOND DAY, OMOLOLA OGUNYEMI, PHD, FACMI, FROM CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE, TACKLED THE URGENT ISSUE OF HEALTH DISPARITIES IN UNDERSERVED COMMUNITIES. OGUNYEMI'S FOCUS ON BIOMEDICAL INFORMATICS TOOLS AND TECHNIQUES AIMED TO ADDRESS THE GAP IN HEALTHCARE ACCESS, ESPECIALLY IN AREAS WITH LIMITED RESOURCES, LEAVING ATTENDEES INSPIRED BY HER DEDICATION TO EQUITABLE HEALTHCARE. THE CONFERENCE ALSO FEATURED AN IMPRESSIVE POSTER SESSION, SHOWCASING 40 DIVERSE PRESENTATIONS COVERING TOPICS FROM "GENE NETWORK PROFILING FOR PREDICTION OF BREAST CANCER DEVELOPMENT" TO "A COMPUTATIONAL FRAMEWORK TO IMPROVE MATCHING IN CASE-CONTROL STUDY DESIGNS." EACH PRESENTER HAD THE OPPORTUNITY TO SHARE THEIR RESEARCH ON THE MAIN STAGE, WITH FOUR STANDOUT STUDENTS EARNING CASH PRIZES FOR THEIR CONTRIBUTIONS. THE CONFERENCE ALSO PROVIDED A UNIQUE NETWORKING PLATFORM FOR ATTENDEES TO CONNECT WITH REGIONAL EXPERTS AND PEERS, FOSTERING POTENTIAL COLLABORATIONS AND CAREER ADVANCEMENTS IN THE DYNAMIC FIELD OF INFORMATICS. AS TECHNOLOGY CONTINUES TO RESHAPE HEALTHCARE, THIS CONFERENCE SERVES AS A VITAL CATALYST FOR INNOVATION AND POSITIVE CHANGE AT THE NEXUS OF HEALTHCARE AND TECHNOLOGY. -ONE HEALTH DAY: UNITING ACTION FOR ONE HEALTH - SHEDDING LIGHT ON VECTOR-BORNE ILLNESSES IN THE SPIRIT OF COLLABORATION, BIONEXUS KC, KANSAS STATE UNIVERSITY, THE UNIVERSITY OF KANSAS-EDWARDS, AND THE UNIVERSITY OF KANSAS MEDICAL CENTER JOINED FORCES TO PRESENT KC ONE HEALTH DAY. WITH A FOCUS ON THE INTERCONNECTEDNESS OF HUMAN, ANIMAL, AND ENVIRONMENTAL HEALTH, KC ONE HEALTH DAY UNDERSCORES THE IMPERATIVE OF COLLABORATIVE SOLUTIONS TO HEALTH CHALLENGES. THIS YEAR'S THEME, "VECTOR-BORNE ILLNESSES," SHED LIGHT ON DISEASES TRANSMITTED BY VECTORS SUCH AS MOSQUITOES, TICKS, FLEAS, AND FLIES, CARRYING PATHOGENS THAT CAN AFFECT BOTH HUMANS AND ANIMALS. FEATURING 20 POSTERS FROM STUDENTS AT VARIOUS ACADEMIC LEVELS, THE EVENT PROVIDED A PLATFORM FOR SHARING RESEARCH AND FOSTERING DIALOGUE AMONG EMERGING RESEARCHERS, PROFESSIONALS, AND PEERS. REGIONAL EXPERTS, INCLUDING BRIAN HERRIN, PHD, DVM FROM KANSAS STATE UNIVERSITY, D. CHRISTOPHER ROGERS, PHD FROM THE KANSAS BIOLOGICAL SURVEY AND THE BIODIVERSITY INSTITUTE AT THE UNIVERSITY OF KANSAS, AND KELLIE WARK, MD, MPH, FROM THE UNIVERSITY OF KANSAS MEDICAL CENTER, SHARED INSIGHTS INTO THE COLLABORATIVE EFFORTS ESSENTIAL FOR EFFECTIVELY ADDRESSING GLOBAL HEALTH CHALLENGES. KC ONE HEALTH DAY UNITED EXPERTS, STUDENTS, AND PROFESSIONALS UNDER THE BANNER OF COLLABORATION, UNDERSCORING THE REMARKABLE POTENTIAL OF A COLLECTIVE EFFORT TO PROPEL GLOBAL HEALTH ENDEAVORS THROUGH A ONE HEALTH LENS. 13. SOCIAL MEDIA BIONEXUS KC SERVES AS A RESOURCE FOR LIFE SCIENCES NEWS FROM MANHATTAN TO COLUMBIA, USING THE FOLLOWING COMMUNICATION TOOLS: -CONNECTION BLOG: HTTPS://BIONEXUSKC.ORG/CATEGORY/NEXUS-CONNECTION/ -EXPERT EXCHANGE VIDEO SERIES: HTTPS://BIONEXUSKC.ORG/VIDEO_CATEGORY/EXPERT-EXCHANGE/ |
| FORM 990, PART VI, SECTION B, LINE 11B | FORM 990 IS REVIEWED BY THE AUDIT COMMITTEE. THE FULL BOARD OF DIRECTORS RECEIVES A COPY OF THE FORM PRIOR TO FILING WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. |
| FORM 990, PART VI, SECTION B, LINE 15A | COMPENSATION OF THE ORGANIZATION'S PRESIDENT & CEO IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. THE ORGANIZATION USES A COMPENSATION COMMITTEE AND CONDUCTS A COMPENSATION STUDY TO FACILITATE THE COMPENSATION PROCESS. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST. |
| FORM 990, PART IX, LINE 11G | CONSULTANTS: PROGRAM SERVICE EXPENSES 49,075. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 49,075. PAYROLL PROCESSING FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 21,439. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 21,439. DIGITAL HEALTH KC CONSULTANTS: PROGRAM SERVICE EXPENSES 196,967. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 196,967. |
| FORM 990, PART XI, LINE 9: | RECOVERY OF PRIOR YEAR GRANTS 1,187. |
| FORM 990, PART XII, LINE 1: | THE ORGANIZATION'S FINANCIAL STATEMENTS HAVE BEEN PREPARED ON THE MODIFIED CASH BASIS OF ACCOUNTING, WHICH IS A BASIS OF ACCOUNTING OTHER THAN ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA. UNDER THIS METHOD OF ACCOUNTING, PROPERTY AND EQUIPMENT IS CAPITALIZED AS AN ASSET ON THE STATEMENTS OF ASSETS AND NET ASSETS - MODIFIED CASH BASIS, AND DEPRECIATION EXPENSE AND GAINS AND LOSSES ON DISPOSAL OF PROPERTY AND EQUIPMENT ARE RECORDED ON THE STATEMENTS OF REVENUES, EXPENSES AND CHANGES IN NET ASSETS - MODIFIED CASH BASIS. ADDITIONALLY, INVESTMENTS ARE RECORDED AS AN ASSET ON THE STATEMENTS OF ASSETS AND NET ASSETS - MODIFIED CASH BASIS, AND GAINS AND LOSSES RELATED TO THE INVESTMENTS ARE RECORDED ON THE STATEMENTS OF REVENUES, EXPENSES AND CHANGES IN NET ASSETS - MODIFIED CASH BASIS. ALL OTHER ELEMENTS OF THE FINANCIAL STATEMENTS ARE MAINTAINED ON THE CASH BASIS OF ACCOUNTING. |
| FORM 990, PART XII, LINE 2C: | THE ORGANIZATION HAS AN AUDIT COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE FINANCIAL STATEMENT AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. THIS PROCESS HAS NOT CHANGED FROM PRIOR YEARS. |
| Software ID: | |
| Software Version: |